X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Wockhardt with Lupin Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WOCKHARDT LTD. vs LUPIN LTD - Comparison Results

WOCKHARDT LTD.    Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WOCKHARDT LTD. LUPIN LTD WOCKHARDT LTD./
LUPIN LTD
 
P/E (TTM) x -11.8 161.0 - View Chart
P/BV x 2.4 3.0 78.8% View Chart
Dividend Yield % 1.4 0.8 167.0%  

Financials

 WOCKHARDT LTD.   LUPIN LTD
EQUITY SHARE DATA
    WOCKHARDT LTD.
Mar-17
LUPIN LTD
Mar-17
WOCKHARDT LTD./
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs1,1291,750 64.5%   
Low Rs6271,384 45.3%   
Sales per share (Unadj.) Rs363.1387.4 93.7%  
Earnings per share (Unadj.) Rs-20.456.6 -36.1%  
Cash flow per share (Unadj.) Rs-7.076.8 -9.1%  
Dividends per share (Unadj.) Rs10.007.50 133.3%  
Dividend yield (eoy) %1.10.5 237.9%  
Book value per share (Unadj.) Rs301.8298.9 101.0%  
Shares outstanding (eoy) m110.55451.58 24.5%   
Bonus/Rights/Conversions ISESOPS-  
Price / Sales ratio x2.44.0 59.8%   
Avg P/E ratio x-42.927.7 -155.2%  
P/CF ratio (eoy) x-125.920.4 -617.3%  
Price / Book Value ratio x2.95.2 55.5%  
Dividend payout %-48.913.2 -369.3%   
Avg Mkt Cap Rs m97,063707,513 13.7%   
No. of employees `0006.816.8 40.3%   
Total wages/salary Rs m9,66528,495 33.9%   
Avg. sales/employee Rs Th5,931.810,418.3 56.9%   
Avg. wages/employee Rs Th1,428.11,697.0 84.2%   
Avg. net profit/employee Rs Th-334.01,523.0 -21.9%   
INCOME DATA
Net Sales Rs m40,146174,943 22.9%  
Other income Rs m1,1431,065 107.3%   
Total revenues Rs m41,289176,008 23.5%   
Gross profit Rs m12844,931 0.3%  
Depreciation Rs m1,4899,122 16.3%   
Interest Rs m2,2531,525 147.7%   
Profit before tax Rs m-2,47235,349 -7.0%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-2119,785 -2.2%   
Profit after tax Rs m-2,26025,575 -8.8%  
Gross profit margin %0.325.7 1.2%  
Effective tax rate %8.527.7 30.9%   
Net profit margin %-5.614.6 -38.5%  
BALANCE SHEET DATA
Current assets Rs m46,160119,542 38.6%   
Current liabilities Rs m19,25861,206 31.5%   
Net working cap to sales %67.033.3 201.0%  
Current ratio x2.42.0 122.7%  
Inventory Days Days10176 132.6%  
Debtors Days Days9490 104.7%  
Net fixed assets Rs m40,165131,660 30.5%   
Share capital Rs m553903 61.2%   
"Free" reserves Rs m32,814134,073 24.5%   
Net worth Rs m33,367134,976 24.7%   
Long term debt Rs m31,90356,478 56.5%   
Total assets Rs m89,687266,073 33.7%  
Interest coverage x-0.124.2 -0.4%   
Debt to equity ratio x1.00.4 228.5%  
Sales to assets ratio x0.40.7 68.1%   
Return on assets %010.2 -0.1%  
Return on equity %-6.818.9 -35.8%  
Return on capital %-0.319.3 -1.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m9,12181,885 11.1%   
Fx outflow Rs m2,13321,506 9.9%   
Net fx Rs m6,98860,378 11.6%   
CASH FLOW
From Operations Rs m-2,69541,148 -6.5%  
From Investments Rs m-6,863-25,287 27.1%  
From Financial Activity Rs m12,5454,332 289.6%  
Net Cashflow Rs m3,01020,193 14.9%  

Share Holding

Indian Promoters % 74.5 46.6 159.9%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 2.3 11.3 20.4%  
FIIs % 7.7 31.9 24.1%  
ADR/GDR % 0.1 0.0 -  
Free float % 15.4 10.1 152.5%  
Shareholders   67,757 98,259 69.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WOCKHARDT LTD. With:   ALEMBIC LTD  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  SHASUN PHARMA  

Compare WOCKHARDT LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Metal Stocks Drag(09:30 am)

Asian share markets slipped in the opening trade today as investors digested the escalation in trade tensions between the US and China after both countries announced tariffs last week.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jun 18, 2018 11:35 AM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. 5-YR ANALYSIS

COMPARE WOCKHARDT LTD. WITH

MARKET STATS